​

InMed Pharmaceuticals (INM) Revenue & Revenue Breakdown

OverviewOwnershipFinancialsChart

InMed Pharmaceuticals Revenue Highlights

Latest Revenue (Y)

$4.94B

Latest Revenue (Q)

$1.30M

InMed Pharmaceuticals Revenue by Period

InMed Pharmaceuticals Revenue by Year

DateRevenueChange
2025-06-30$4.94B78504.30%
2024-06-30$6.29M14.77%
2023-06-30$5.48M290.57%
2022-06-30$1.40M100.00%
2021-06-30-100.00%
2020-06-30-100.00%
2019-06-30-100.00%
2018-06-30-100.00%
2017-06-30-100.00%
2016-06-30-100.00%
2015-06-30-100.00%
2014-06-30-100.00%
2013-06-30-100.00%
2012-06-30--100.00%
2011-06-30$39.66K-50.09%
2010-06-30$79.46K-52.82%
2009-06-30$168.42K-72.98%
2008-06-30$623.37K-24.51%
2007-06-30$825.79K-70.06%
2006-06-30$2.76M-34.85%
2005-06-30$4.23M102.27%
2004-07-31$2.09M1027.38%
2003-07-31$185.61K1248.04%
2002-07-31$13.77K463.84%
2001-07-31$2.44K-

InMed Pharmaceuticals generated $4.94B in revenue during NA 2025, up 78504.30% compared to the previous quarter, and up Infinity% compared to the same period a year ago.

InMed Pharmaceuticals Revenue by Quarter

DateRevenueChange
2025-06-30$1.30M2.33%
2025-03-31$1.27M14.76%
2024-12-31$1.11M-11.87%
2024-09-30$1.26M-28.18%
2024-06-30$1.75M10.28%
2024-03-31$1.59M-3.20%
2023-12-31$1.64M34.60%
2023-09-30$1.22M-60.11%
2023-06-30$3.06M118.93%
2023-03-31$1.40M121.54%
2022-12-31$631.22K43.54%
2022-09-30$439.74K-33.65%
2022-06-30$662.79K71.34%
2022-03-31$386.82K14.49%
2021-12-31$337.86K100.00%
2021-09-30-100.00%
2021-06-30-100.00%
2021-03-31-100.00%
2020-12-31-100.00%
2020-09-30-100.00%
2020-06-30-100.00%
2020-03-31-100.00%
2019-12-31-100.00%
2019-09-30-100.00%
2019-06-30-100.00%
2019-03-31-100.00%
2018-12-31-100.00%
2018-09-30-100.00%
2018-06-30-100.00%
2018-03-31-100.00%
2017-12-31-100.00%
2017-09-30-100.00%
2017-06-30-100.00%
2017-03-31-100.00%
2016-12-31-100.00%
2016-09-30-100.00%
2016-06-30-100.00%
2016-03-31-100.00%
2015-12-31-100.00%
2015-09-30-100.00%
2015-06-30-100.00%
2015-03-31-100.00%
2014-12-31-100.00%
2014-09-30-100.00%
2014-06-30-100.00%
2014-03-31-100.00%
2013-12-31-100.00%
2013-09-30-100.00%
2013-06-30-100.00%
2013-03-31-100.00%
2012-12-31-100.00%
2012-09-30-100.00%
2012-06-30-100.00%
2012-03-31-100.00%
2011-12-31-100.00%
2011-09-30--100.00%
2011-06-30$138.33-99.33%
2011-03-31$20.78K128.68%
2010-12-31$9.09K2.82%
2010-09-30$8.84K-82.89%
2010-06-30$51.66K721.74%
2010-03-31$6.29K113.95%
2009-12-31$2.94K-83.34%
2009-09-30$17.64K-41.52%
2009-06-30$30.16K238.31%
2009-03-31$8.92K-72.88%
2008-12-31$32.88K-71.77%
2008-09-30$116.48K-118.92%
2008-06-30$-615.65K-

InMed Pharmaceuticals generated $1.30M in revenue during Q4 2025, up 2.33% compared to the previous quarter, and up 81.97% compared to the same period a year ago.

InMed Pharmaceuticals Revenue Breakdown

InMed Pharmaceuticals Revenue Breakdown by Product

Quarterly Revenue by Product

Product/ServiceSep 25
Reportable Subsegments$1.12M

InMed Pharmaceuticals's latest quarterly revenue breakdown by segment (product or service), as of Sep 25: Reportable Subsegments (100.00%).

InMed Pharmaceuticals Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
INMInMed Pharmaceuticals$4.94B$1.30M
JAGXJaguar Health$11.56M$3.04M
BDRXBiodexa Pharmaceuticals$381.00K$41.50K
SILOSilo Pharma$72.10K$18.02K
KZIAKazia Therapeutics$555.00$5.00
ESLAEstrella Immunopharma--
CNSPCNS Pharmaceuticals--
GNPXGenprex--
BIVIBioVie--
GLMDGalmed Pharmaceuticals--
GRIGRI Bio--

INM Revenue FAQ

What is InMed Pharmaceuticals’s yearly revenue?

InMed Pharmaceuticals's yearly revenue for 2025 was $4.94B, representing an increase of 78504.30% compared to 2024. The company's yearly revenue for 2024 was $6.29M, representing an increase of 14.77% compared to 2023. INM's yearly revenue for 2023 was $5.48M, representing an increase of 290.57% compared to 2022.

What is InMed Pharmaceuticals’s quarterly revenue?

InMed Pharmaceuticals's quarterly revenue for Q4 2025 was $1.3M, a 2.33% increase from the previous quarter (Q3 2025), and a -25.67% decrease year-over-year (Q4 2024). The company's quarterly revenue for Q3 2025 was $1.27M, a 14.76% increase from the previous quarter (Q2 2025), and a -19.90% decrease year-over-year (Q3 2024). INM's quarterly revenue for Q2 2025 was $1.11M, a -11.87% decrease from the previous quarter (Q1 2025), and a -32.44% decrease year-over-year (Q2 2024).

What is InMed Pharmaceuticals’s revenue growth rate?

InMed Pharmaceuticals's revenue growth rate for the last 3 years (2023-2025) was 90116.44%, and for the last 5 years (2021-2025) was 0%.